Cambridge Healthtech Institute’s Fourth Annual

Point-of-Care Diagnostics

Examining Rapid Diagnostics from the Clinic to Consumer

February 19-20, 2015 | Moscone North Convention Center | San Francisco, CA
Part of the 22nd International Molecular Medicine Tri-Conference


Point-of-care testing is becoming a crucial component of healthcare both in an out of the clinical setting. Rapid care centers are now commonplace in many pharmacies and mobile diagnostics applications are allowing the consumer to take their health into their own hands. Cambridge Healthtech Institute's Fourth Annual Point-of-Care Diagnostics symposium will examine how point of care is being used in the clinic, in pharmacies, and by the consumer. Point-of-care test developers and end users will address barriers to implementation and present solutions to encourage adoption. Finally, innovative point-of-care and mobile health technologies will be presented to showcase the latest tools and provide insights into the future of the field.


KEYNOTE PRESENTATION: The Evolving Approach to Direct-to-Patient Care and the Digital Revolution

Jeffrey A. Dubois, Ph.D., Vice President, Medical & Scientific Affairs, Nova Biomedical

Point-of-Care Testing in Patient Care: A Real World Experience

Elizabeth A. Wagar, M.D., Professor and Chair, Laboratory Medicine, MD Anderson Cancer Center

Point-of-Care Test Device Design: Practical Tips from the User

Valerie Ng, M.D., Ph.D., Chair, Laboratory Medicine & Pathology, Alameda Heath System/Highland General Hospital


Talk Title to be Announced

Steve Cashman, Founder & CEO, Health Spot


POC in High Burden Disease Countries 


Moderator: N. Reginald Beer, Ph.D., Medical Diagnostics Initiative Leader, Center for Micro and Nanotechnologies, Lawrence Livermore National Laboratory

Panelists: Philip L. Felgner, Ph.D., Director, Protein Microarray Laboratory, Infectious Disease; Project Scientist, Epidemiology, University of California, Irvine School of Medicine
Adithya Cattamanchi, M.D., Assistant Professor, University of California, San Francisco School of Medicine


Development of a Handheld MDx and Sequencing Device

Jonathan O'Halloran, CSO and Co-Founder, Board, QuantuMDx Group

Neurotrack: Transforming the Diagnosis of Alzheimer's

Elli Kaplan, CEO, Neurotrack

Detection and Treatment of Autism through Smartphone-Enabled Evaluation

Jessica Owens, Founder & CEO, Acumen

Mobile Devices and Artificial Intelligence in Heart Attack Follow Up Care

Jacob Sattelmair, D.Sc., M.Sc., Chief Executive Officer, Co-founder, WellFrame

Lucigen DiagnosticsReimagining the Future of Point-of-Care Molecular Diagnostics for Infectious Disease

 Hemanth Shenoi, Ph.D., Director, Business Development, Lucigen Corporation

For more details on the conference, please contact:
Samantha Lewis
Conference Director
Cambridge Healthtech Institute
T: (+1) 781-972-5461

For partnering and sponsorship information, please contact:
Jon Stroup (Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483

Joseph Vacca (Companies L-Z)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431


  2015 Plenary Sessions 

2015 MMTC Prelim Agenda 

Premier Sponsors:


Jackson Laboratory - small logo 

Leica Biosystems 




Thomson Reuters-Large 

Local Partners:



City of SSF